Wenbin Li, Rong Wang, Hua Xie, Juanhong Zhang, Xiaoyu Wu, Zhengping Jia
Department of Pharmacology, College of Pharmacy, Forth Military Medical University, Xi'an, 710032, China.
Key Laboratory of the Plateau Environmental Damage Control, Lanzhou General Hospital of Lanzhou Military Command, PLA, Lanzhou, 730050, China.
Cell Biochem Biophys. 2015 May;72(1):27-36. doi: 10.1007/s12013-014-0397-3.
A series of pathological, physiological, and biochemical changes, even anatomical histological changes happen while humans arrive at the high plateau region from plain area. There is a certain relationship between the body's compensatory or decompensated adjustments to the environment and the changes of absorption, distribution, metabolism, and excretion of drugs. The objective of the study is to observe the effects of acute exposure to high altitude at 4,010 m on pharmacokinetics of propranolol in rats, and to provide basis and new ideas to adjust drug dosage and administration, so as to promote rational drug use in high altitude. 28 healthy male wistar rats were randomly divided into four groups, group A and B which were in plain area; group C and D which were acutely exposed to high altitude by aviation; group A and C were used for pharmacokinetics determination of propranolol, while group B and D had no drug administration for physiological and pathological changes research at high altitude. The pharmacokinetics of propranolol significantly changed; area under curve, C max (the peak concentration), mean residence time, and t 1/2 (the biological half-life) increased significantly by 481.72, 398.94, 44.87, and 58.77 %, respectively; clearance and V (apparent volume of distribution) decreased by 81.50 and 70.56 %, respectively, after acute exposure to high altitude at 4,010 m; Analytic results show that pH, buffer base, base excess, ctCO2 (content of total carbon dioxide), sO2 (oxygen saturation of arterial blood), pO2 (oxygen tension of arterial blood), and cNa(+) severely decreased by 2.43, 630.00, 311.00, 11.48, 91.38, 76.22, and 2.82 %, respectively, while pCO2 (carbon dioxide tension of arterial blood) and cCl(-) significantly increased by 47.40 and 6.76 %. Lactate dehydrogenase and total protein significantly decreased by 58.44 and 26.82 %, while total bilirubin and alkaline phosphatase severely increased by 338 and 24.94 % after acute exposure to high altitude at 4,010 m. Pathological research shows that alveolar wall is hyperemic, edematous, and incrassate; alveolus epithelium becomes hyperplastic while neutrophilic granulocytes infiltrate; brain neurons are edematous and perivascular space occurred; neurons of seahorse are metamorphic and karyopyknotic; mesangial cells are hyperplastic in kidney glomerulus tissue. We should reduce the dosage or extend the dosing interval in high altitude to maintain the drug concentration in therapeutic window since velocity of metabolism and excretion are reduced.
当人类从平原地区进入高海拔地区时,会发生一系列病理、生理和生化变化,甚至出现解剖组织学变化。机体对环境的代偿或失代偿性调节与药物的吸收、分布、代谢和排泄变化之间存在一定关系。本研究的目的是观察急性暴露于4010米高海拔对大鼠普萘洛尔药代动力学的影响,为调整药物剂量和给药方式提供依据和新思路,以促进高海拔地区合理用药。28只健康雄性Wistar大鼠随机分为四组,A组和B组在平原地区;C组和D组通过航空急性暴露于高海拔地区;A组和C组用于普萘洛尔药代动力学测定,而B组和D组不给予药物,用于研究高海拔地区的生理和病理变化。普萘洛尔的药代动力学发生了显著变化;曲线下面积、Cmax(峰浓度)、平均驻留时间和t1/2(生物半衰期)分别显著增加了481.72%、398.94%、44.87%和58.77%;在急性暴露于4010米高海拔后,清除率和V(表观分布容积)分别下降了81.50%和70.56%;分析结果表明,pH、缓冲碱、碱剩余、ctCO2(总二氧化碳含量)、sO2(动脉血氧饱和度)、pO2(动脉血氧分压)和cNa(+)分别严重下降了2.43%、630.00%、311.00%、11.48%、91.38%、76.22%和2.82%,而pCO2(动脉血二氧化碳分压)和cCl(-)分别显著增加了47.40%和6.76%。急性暴露于4010米高海拔后,乳酸脱氢酶和总蛋白分别显著下降了58.44%和26.82%,而总胆红素和碱性磷酸酶分别严重增加了338%和24.94%。病理研究表明,肺泡壁充血、水肿、增厚;肺泡上皮细胞增生,同时有中性粒细胞浸润;脑神经元水肿,出现血管周围间隙;海马神经元变形、核固缩;肾小球组织中的系膜细胞增生。由于代谢和排泄速度降低,在高海拔地区应减少药物剂量或延长给药间隔,以维持治疗窗内的药物浓度。